255 related articles for article (PubMed ID: 29972326)
1. Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
Kang JH; Cho J; Ko YT
J Drug Target; 2019 Jan; 27(1):103-110. PubMed ID: 29972326
[TBL] [Abstract][Full Text] [Related]
2. Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood-brain barrier opening.
Ohta S; Kikuchi E; Ishijima A; Azuma T; Sakuma I; Ito T
Sci Rep; 2020 Oct; 10(1):18220. PubMed ID: 33106562
[TBL] [Abstract][Full Text] [Related]
3. The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study.
Betzer O; Shilo M; Opochinsky R; Barnoy E; Motiei M; Okun E; Yadid G; Popovtzer R
Nanomedicine (Lond); 2017 Jul; 12(13):1533-1546. PubMed ID: 28621578
[TBL] [Abstract][Full Text] [Related]
4. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
5. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system.
Ha SW; Hwang K; Jin J; Cho AS; Kim TY; Hwang SI; Lee HJ; Kim CY
Int J Nanomedicine; 2019; 14():3743-3752. PubMed ID: 31213800
[No Abstract] [Full Text] [Related]
7. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma.
Peng L; Liang Y; Zhong X; Liang Z; Tian Y; Li S; Liang J; Wang R; Zhong Y; Shi Y; Zhang X
Int J Nanomedicine; 2020; 15():1363-1372. PubMed ID: 32184591
[TBL] [Abstract][Full Text] [Related]
9. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
10. Tailoring functional nanostructured lipid carriers for glioblastoma treatment with enhanced permeability through in-vitro 3D BBB/BBTB models.
Zwain T; Alder JE; Sabagh B; Shaw A; Burrow AJ; Singh KK
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111774. PubMed ID: 33579439
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
Lim SH; Yee GT; Khang D
Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
[TBL] [Abstract][Full Text] [Related]
12. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
13. A multiparametric study of gold nanoparticles cytotoxicity, internalization and permeability using an
Enea M; Peixoto de Almeida M; Eaton P; Dias da Silva D; Pereira E; Soares ME; Bastos ML; Carmo H
Nanotoxicology; 2019 Sep; 13(7):990-1004. PubMed ID: 31106633
[TBL] [Abstract][Full Text] [Related]
14. An Advanced
Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
[TBL] [Abstract][Full Text] [Related]
15. Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.
Lu VM; McDonald KL; Townley HE
Nanomedicine (Lond); 2017 Oct; 12(19):2389-2401. PubMed ID: 28868972
[TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
17. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL
Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720
[TBL] [Abstract][Full Text] [Related]
18. Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound.
Coluccia D; Figueiredo CA; Wu MY; Riemenschneider AN; Diaz R; Luck A; Smith C; Das S; Ackerley C; O'Reilly M; Hynynen K; Rutka JT
Nanomedicine; 2018 Jun; 14(4):1137-1148. PubMed ID: 29471172
[TBL] [Abstract][Full Text] [Related]
19. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles.
Straehla JP; Hajal C; Safford HC; Offeddu GS; Boehnke N; Dacoba TG; Wyckoff J; Kamm RD; Hammond PT
Proc Natl Acad Sci U S A; 2022 Jun; 119(23):e2118697119. PubMed ID: 35648828
[TBL] [Abstract][Full Text] [Related]
20. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
